| 1 |
32930615 | Development of graphene based nanocomposites towards medical and biological applications. | 2020 Dec |
1 |
| 2 |
28685075 | Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series. | 2017 Jul |
1 |
| 3 |
27843533 | An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation. | 2016 |
1 |
| 4 |
22946345 | Nedaplatin and irinotecan for patients with recurrent small cell lung cancer. | 2012 |
1 |
| 5 |
21210765 | RECQL5 is an important determinant for camptothecin tolerance in human colorectal cancer cells. | 2011 Oct |
1 |
| 6 |
17552365 | Feasible combination chemotherapy with nedaplatin and irinotecan for patients with non-small cell lung cancer and multiple high-risk factors. | 2007 |
1 |
| 7 |
15844664 | Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer. | 2004 Dec |
1 |
| 8 |
12569373 | Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer. | 2003 Feb 10 |
1 |
| 9 |
11773147 | Irinotecan dosing: does the CPT in CPT-11 stand for "Can't Predict Toxicity"? | 2002 Jan 1 |
2 |
| 10 |
10912947 | Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography. | 2000 Jun |
1 |
| 11 |
10569939 | Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks. | 1999 Nov 23 |
1 |
| 12 |
7766631 | Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. | 1995 May 30 |
1 |
| 13 |
8070019 | 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials. | 1994 |
4 |
| 14 |
8074481 | Establishment of a CPT-11-resistant human ovarian cancer cell line. | 1994 May-Jun |
1 |